Merck & Co

Buffett’s Berkshire pares drug holdings, sheds Axalta, Biogen

Warren Buffett's Berkshire Hathaway Inc (BRKa.N) said on Monday it trimmed or eliminated its stakes in several pharmaceutical companies, and reported a…

4 years ago

Bristol-Myers, Eisai in up to $3.1 bln deal to develop cancer drug candidate

Bristol-Myers Squibb Co (BMY.N) and Eisai Co said on Thursday they had entered into an agreement worth up to $3.10…

4 years ago